Please note that this product was withdrawn from the Community Register of designated orphan medicinal products in November 2009 on request of the sponsor.
On, 20 November 2001 orphan designation (EU/3/01/064) was granted by the European Commission to Icon Clinical Research UK Ltd., United Kingdom, for abetimus sodium for the treatment of lupus nephritis.
The sponsorship was transferred to La Jolla Limited, United Kingdom in September 2005.
|Disease / condition||
Treatment of lupus nephritis
|Date of first decision||
|EU designation number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.